These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36081275)

  • 1. Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran.
    Taziki M; Rajaei S; Firouzei G; Hashemzadeh F; Rajabalian M; Mansoury M; Sedaghat S; Ghahraman F; Ghasemi-Kebria F; Weiderpass E; Roshandel G
    Cancer Epidemiol; 2022 Oct; 80():102247. PubMed ID: 36081275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Head and Neck Cancers in Northern Iran: A 10-Year Trend Study From Golestan Province.
    Taziki MH; Fazel A; Salamat F; Sedaghat SM; Ashaari M; Poustchi H; Shakeri R; Hoseinpoor R; Hasanpour-Heidari S; Roshandel G
    Arch Iran Med; 2018 Sep; 21(9):406-411. PubMed ID: 30221531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013.
    Salamat F; Aryannia A; Rajaei S; Naeimi-Tabiei M; Afghani R; Sedaghat SM; Naeimi-Tabiei E; Salamat F; Hosseinpour R; Fazel A; Araghi M; Roshandel G
    Arch Iran Med; 2021 Jan; 24(1):1-6. PubMed ID: 33588561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental cervical metastases from thyroid carcinoma during neck dissection.
    Périé S; Torti F; Lefevre M; Chabbert-Buffet N; Jafari A; Lacau St Guily J
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Dec; 133(6):383-386. PubMed ID: 27474239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy?
    Guzzo M; Quattrone P; Seregni E; Bianchi R; Mattavelli F
    Head Neck; 2007 Jan; 29(1):33-7. PubMed ID: 16983696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.
    Chen JH; Yen YC; Chen TM; Yuan KS; Lee FP; Lin KC; Lai MT; Wu CC; Chang CL; Wu SY
    Cancer Med; 2017 Jan; 6(1):142-153. PubMed ID: 27987269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine cancer in Iran: based on cancer registry system.
    Haghpanah V; Soliemanpour B; Heshmat R; Mosavi-Jarrahi AR; Tavangar SM; Malekzadeh R; Larijani B
    Indian J Cancer; 2006; 43(2):80-5. PubMed ID: 16790945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
    Lee JJW; Kunaratnam V; Kim CJH; Pienkowski M; Hueniken K; Sahovaler A; Lam ACL; Davies JC; Brown CM; De Almeida JR; Huang SH; Waldron JN; Spreafico A; Hung RJ; Xu W; Goldstein DP; Liu G
    Cancer; 2023 Mar; 129(6):867-877. PubMed ID: 36653915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a second primary thyroid carcinoma on patients with head and neck squamous cell carcinoma.
    Tolisano AM; Klem C; Lustik MB; Sniezek JC; Golden JB
    Head Neck; 2016 Apr; 38 Suppl 1():E890-4. PubMed ID: 25965105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
    Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
    Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
    Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
    Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
    Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
    Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
    Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
    Trials; 2014 Nov; 15():469. PubMed ID: 25432788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.
    Mazul AL; Hartman C; Kramer J; White DL; Royse K; Raychaudhury S; Sandulache V; Ahmed ST; Richardson P; Sikora AG; Chiao E
    Cancer Med; 2020 Dec; 9(24):9326-9335. PubMed ID: 33094910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012.
    Nemati S; Saeedi E; Roshandel G; Nahvijou A; Badakhshan A; Akbari M; Sedaghat SM; Hasanpour-Heidari S; Hosseinpour R; Salamat F; Lotfi F; Khosravi A; Soerjomataram I; Bray F; Zendehdel K
    Cancer Epidemiol; 2022 Apr; 77():102089. PubMed ID: 35042146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of obstructive sleep apnea after treatment of head and neck squamous cell carcinoma: a cross-sectional study.
    Gavidia R; Dunietz GL; O'Brien LM; Schütz SG; Spector ME; Swiecicki PL; Chervin RD
    J Clin Sleep Med; 2022 Jun; 18(6):1681-1686. PubMed ID: 35236549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.